Chungcheongnam-do, South Korea

Jaesung No

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jaesung No. Retrieved from https://idiyas.com/inventor/jaesung-no

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jaesung No: Innovator in Anticancer Agents

Introduction

Jaesung No is a prominent inventor based in Chungcheongnam-do, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. His innovative work has led to the creation of a unique compound that holds promise for cancer treatment.

Latest Patents

Jaesung No holds a patent for a compound titled "5-(1,3-Diaryl-1H-pyrazol-4-ylmethylene)-thiazolidine-2,4-dione derivatives useful as anticancer agent." This invention relates to a derivative or its pharmaceutically acceptable salts, along with a method for preparing the same. The compound is part of an anticancer agent composition that includes it as an active ingredient.

Career Highlights

Jaesung No is affiliated with the Korea Research Institute of Chemical Technology. His work at this esteemed institution has allowed him to focus on the synthesis and application of novel chemical compounds in the fight against cancer. His dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Jaesung No collaborates with talented colleagues, including Hyoung Rae Kim and Min Jung Seo. Their combined expertise enhances the research efforts at the Korea Research Institute of Chemical Technology.

Conclusion

Jaesung No's contributions to the development of anticancer agents exemplify the impact of innovative research in medicine. His work continues to inspire advancements in cancer treatment and highlights the importance of collaboration in scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…